Psychiatry & Neurology Doctors in Bossier City, LA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Claudia Orellana, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 4440 Viking Dr, Ste 300, Bossier City, LA 71111 Phone: 318-584-7137    Fax: 318-584-7140

Sanjeevi C. Tivakaran, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 220, Bossier City, LA 71111 Phone: 318-752-7840    Fax: 318-752-7845

Dr. Sachin Babanao Thorat, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 310, Bossier City, LA 71111 Phone: 318-741-2900    Fax: 318-741-2999

Lionel Guillaume, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3018 Old Minden Rd, Suite 1212, Bossier City, LA 71112 Phone: 318-747-1665    Fax: 318-747-1597

Dr. Connie Hale, NP Psychiatry & Neurology - Addiction Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3018 Old Minden Rd Ste 1117, Bossier City, LA 71112 Phone: 318-746-1935    Fax: 318-746-2514

Dr. Lee Stevens, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1007 Gould Dr Ste 1, Bossier City, LA 71111 Phone: 318-422-7154    Fax: 850-203-1448

News Archive

Appetite-controlling neurons initiate repetitive behaviors seen in OCD, anorexia nervosa

In the absence of food, neurons that normally control appetite initiate complex, repetitive behaviors seen in obsessive-compulsive disorder (OCD), and anorexia nervosa, according to a new study by Yale School of Medicine researchers.

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Antares Pharma, Inc. announced today that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA), is expected in the third quarter of this year.

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

AstraZeneca and Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).

Topically applied simvastatin enhances wound recovery in diabetic mice

Delayed wound healing is a major complication of diabetes because the physiological changes in tissues and cells impair the wound healing process. This can result in additional disease outcomes such as diabetic foot ulcer, a significant cause of morbidity in the growing population of diabetic patients. A new study has found that topically applied simvastatin accelerates wound healing in diabetic mice, suggesting important implications for humans with diabetes.

OX40 molecule responsible for airway inflammation in the lungs

A research team led by Xian Chang Li, MD, PhD, Brigham and Women's Hospital (BWH) Transplantation Research Center, has shed light on how a population of lymphocytes, called CD4+ T cells, mature into various subsets of adult T helper cells.

Read more Medical News

› Verified 3 days ago